No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Investing

CapitalRise secures £250m bank funding line to further accelerate its lending capabilities

by
January 15, 2024
in Investing
0
CapitalRise secures £250m bank funding line to further accelerate its lending capabilities
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Leading prime property finance firm CapitalRise has today announced a new £250m bank funding line, as part of the firm’s wider approach to diversify and increase the resilience of its capital sources and facilitate further lending growth.

This latest funding line is the fifth and largest secured by the firm to date. Alongside variable pricing options, this funding line will now also enable CapitalRise to offer fixed pricing for UK limited company borrowers, providing its customers with greater cost certainty against the current backdrop of interest rate volatility. More will be announced by the firm in the coming months on this new offering.

Since its inception in 2016, CapitalRise has funded property developments across Prime Central London, Prime Outer London and the Prime Home Counties to the value of £859m. The prime property market is renowned for its resilience relative to the wider property market.

CapitalRise has seen strong demand for funding from borrowers and its loan book has grown rapidly as a result. By continuing to diversify and strengthen its funding lines, the firm can respond to this demand and continue to serve borrowers in these exclusive corners of the UK property market with its flexible, bespoke lending solutions.

Uma Rajah, CEO and Co-Founder of CapitalRise, said: “A diverse range of funding lines support the growth of the business and provide us with a resilient and varied capital base. Securing a facility of this scale and nature is a great new addition to our existing partnerships. It is a testament to our depth of expertise and strong track record in this specialist area of the real estate market. We continue to grow the team too, bringing new talent into nearly every department of the business. Combining this new funding line with increased capacity within the team enables us to turbo-charge our growth and serve increasing numbers of borrowers.”

Lee Francis, Head of Origination at CapitalRise, said: “This new facility will enable CapitalRise to continue responding to demand and offer greater volumes of funding for projects in the best locations. Our specialised sector expertise and robust lending practises have allowed us to keep our door wide open to new enquiries, at a time when many other lenders are retrenching from the market. This additional lending capacity and the introduction of fixed pricing also provides cost certainty for borrowers during times of volatile interest rates, and further solidifies our position as the lender of choice for prime property finance in the UK.”

Pip Lashko-Sayers, Associate Director, Capital Markets at CapitalRise, added: “We operate a multi-funded model and retain an ambition to diversify both our capital sources and product range even further to support a wider range of borrowers. Our door remains very much open, and we are always keen to discuss new institutional funding lines to supplement the considerable existing capital resources.

“The sectors that we focus on – Prime Central and Outer London, and the Prime Home Counties – continue to buck trends seen in the wider UK property market, as the prime sectors run on an entirely distinct cycle. There remains a vast range of attractive investment opportunities in our target markets that we are keen to support, particularly with enhanced tools and resources at our disposal.”

Read more:
CapitalRise secures £250m bank funding line to further accelerate its lending capabilities

Previous Post

“Mental Health Struggles? New Employment Support Service Now Available”

Next Post

Government’s free childcare scheme in disarray, charities say

Next Post
Government’s free childcare scheme in disarray, charities say

Government’s free childcare scheme in disarray, charities say

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

Last Day to Give in 2023!

December 31, 2023

The Producer Price Index

September 9, 2023

Is Culture Degeneration Biological or Ideological?

0

0

0

0

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Recent News

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Is Culture Degeneration Biological or Ideological?

May 24, 2025

Price Controls and Drug Shortages in France: A Textbook Case of the Evils of Interventionism

May 24, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.